Michael Gladstone serves as Executive at Day One Biopharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Michael Gladstone has executed 1 insider transactions totaling $11.5M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 17, 2022 involved purchasing 766,667 shares valued at $11.5M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 17, 2022 | DAWN | $11.5M | Purchase | 766,667 | $15.00 | Discretionary |
Michael Gladstone currently holds 766,667 shares of Day One Biopharmaceuticals, Inc. (DAWN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Gladstone has been a net buyer of DAWN stock. They have purchased $11.5M and sold $0 worth of shares.
Michael Gladstone's most recent insider trade was on Jun 17, 2022, when they purchased 766,667 shares at $15.00 per share.
Get notified when new Form 4 filings are submitted